What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Diabetes mellitus
Ingar Holme mainly focuses on Internal medicine, Myocardial infarction, Surgery, Risk factor and Physical therapy.
His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology and Cardiology.
His Cardiology research includes elements of Anesthesia, Simvastatin and Placebo.
His work on Unstable angina is typically connected to Placebo-controlled study as part of general Myocardial infarction study, connecting several disciplines of science.
His study on Surgery also encompasses disciplines like
- Cause of death together with Diabetes mellitus, Hazard ratio and Liver disease,
- Incidence and related Confidence interval.
His study in the field of Hamstring also crosses realms of Injury prevention.
His most cited work include:
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death (1671 citations)
- High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. (1299 citations)
- Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis (1186 citations)
What are the main themes of his work throughout his whole career to date?
Ingar Holme mainly investigates Internal medicine, Cardiology, Endocrinology, Myocardial infarction and Surgery.
Cholesterol, Blood pressure, Risk factor, Apolipoprotein B and Prospective cohort study are among the areas of Internal medicine where Ingar Holme concentrates his study.
His Blood pressure research focuses on subjects like Disease, which are linked to Intensive care medicine.
In his work, Atorvastatin is strongly intertwined with Simvastatin, which is a subfield of Cardiology.
His study focuses on the intersection of Myocardial infarction and fields such as Randomized controlled trial with connections in the field of Physical therapy.
His Surgery study deals with Fluvastatin intersecting with Transplantation.
He most often published in these fields:
- Internal medicine (65.73%)
- Cardiology (27.62%)
- Endocrinology (19.58%)
What were the highlights of his more recent work (between 2010-2018)?
- Internal medicine (65.73%)
- Surgery (19.93%)
- Cardiology (27.62%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Surgery, Cardiology, Proportional hazards model and Hazard ratio.
The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus and Endocrinology.
Within one scientific family, Ingar Holme focuses on topics pertaining to Cause of death under Surgery, and may sometimes address concerns connected to Survival analysis.
His work on Stenosis as part of his general Cardiology study is frequently connected to In patient, thereby bridging the divide between different branches of science.
Ingar Holme interconnects Receiver operating characteristic, Gerontology and Risk factor in the investigation of issues within Proportional hazards model.
His studies deal with areas such as Body mass index, Prospective cohort study, Incidence and Stroke as well as Hazard ratio.
Between 2010 and 2018, his most popular works were:
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death (1671 citations)
- Long-term risks for kidney donors (471 citations)
- Comparison of self-reported versus accelerometer-measured physical activity. (338 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Diabetes mellitus
Ingar Holme spends much of his time researching Internal medicine, Surgery, Physical therapy, Diabetes mellitus and Hazard ratio.
The Internal medicine study combines topics in areas such as Endocrinology and Cardiology.
His biological study spans a wide range of topics, including Creatinine, Fluvastatin and Cause of death.
His Physical therapy study combines topics in areas such as Young adult, Epidemiology, Blood pressure and Risk factor.
He has included themes like Body mass index, Prospective cohort study and Cohort study in his Diabetes mellitus study.
His work carried out in the field of Hazard ratio brings together such families of science as Incidence, Disease and Renal function.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
